Results 21 to 30 of about 920,102 (313)

Adenosine A2A receptors: localization and function [PDF]

open access: yes, 2015
Adenosine is an endogenous purine nucleoside present in all mammalian tissues, that originates from the breakdown of ATP. By binding to its four receptor subtypes (A1, A2A, A2B, and A3), adenosine regulates several important physiological functions at ...
A Brand   +190 more
core   +1 more source

Allowed Drugs in Children’s Sports: Results of a Survey Among Sports Doctors

open access: yesПедиатрическая фармакология, 2015
Relevance. The reception of various vitamin and mineral supplements, dietary supplements and other approved drugs, which enhance physiological capacities of the body, helps to achieve good results in sports.Object of the survey: to study the opinion of ...
E. G. Vershinin, V. V. Delaryu
doaj   +1 more source

Effects of novel antidepressant drugs on mesenchymal stem cell physiology

open access: yesBiomedicine & Pharmacotherapy, 2019
It is known that users of psychotropic drugs often have weight gain, adverse effects on bone mineral density and osteoporosis, but the molecular basis for these side effects is poorly understood. The aim of this study is to evaluate the effects in vitro of duloxetine (a serotonin and norepinephrine reuptake inhibitor) and fluoxetine (a selective ...
Ferroni, Letizia   +5 more
openaire   +4 more sources

From Bench to Bedside: What Do We Know about Imidazothiazole Derivatives So Far?

open access: yesMolecules, 2023
Imidazothiazole derivatives are becoming increasingly important in therapeutic use due to their outstanding physiological activities. Recently, applying imidazothiazole as the core, researchers have synthesized a series of derivatives with biological ...
Mu Guo, Xiangbin Yu, Yi Zhun Zhu, Yue Yu
doaj   +1 more source

Chronic beta-adrenoceptor blockade and human atrial cell electrophysiology: evidence of pharmacological remodelling [PDF]

open access: yes, 2003
<b>Objective:</b> Chronic beta-adrenoceptor antagonist (β-blocker) treatment reduces the incidence of reversion to AF in patients, possibly via an adaptive myocardial response.
Kane, K.A.   +4 more
core   +1 more source

Types and Distribution of Bioactive Polyunsaturated Aldehydes in a Gradient from Mesotrophic to OligotrophicWaters in the Alborán Sea (Western Mediterranean) [PDF]

open access: yes, 2020
Polyunsaturated aldehydes (PUAs) are bioactive molecules suggested as chemical defenses and infochemicals. In marine coastal habitats, diatoms reach high PUA production levels during bloom episodes.
Bartual Magro, Ana   +11 more
core   +1 more source

Prediction of PPAR-α ligand-mediated physiological changes using gene expression profiles

open access: yesJournal of Lipid Research, 2004
Peroxisome proliferator-activated receptor (PPAR)-α controls the transcription of a variety of genes involved in lipid metabolism and is the target receptor for the hypolipidemic drug class of fibrates.
Klaus Stensgaard Frederiksen   +5 more
doaj   +1 more source

Selective COX-2 inhibitors and risk of myocardial infarction [PDF]

open access: yes, 2005
Selective inhibitors of cyclooxygenase- 2 ( COX- 2, ` coxibs') are highly effective anti-inflammatory and analgesic drugs that exert their action by preventing the formation of prostanoids.
Klauss, V.   +3 more
core   +1 more source

Recent advances in understanding adverse effects associated with drugs targeting the serotonin receptor, 5-HT GPCR

open access: yesFrontiers in Global Women's Health, 2022
It has been acknowledged that more women suffer from adverse effects of drugs than men globally. A group of drugs targeting serotonin [5-hydroxytryptamine] (5-HT) binding G-protein-coupled receptors (GPCRs) have been reported to preferentially affect ...
Isabella Marie Jamu, Haruko Okamoto
doaj   +1 more source

The effects of pioglitazone, a PPARγ receptor agonist, on the abuse liability of oxycodone among nondependent opioid users [PDF]

open access: yes, 2016
Aims: Activation of PPARγ by pioglitazone (PIO) has shown some efficacy in attenuating addictive-like responses in laboratory animals. The ability of PIO to alter the effects of opioids in humans has not been characterized in a controlled laboratory ...
Alonzo   +74 more
core   +1 more source

Home - About - Disclaimer - Privacy